Logo image of BWIN

BALDWIN INSURANCE GROUP INC/ (BWIN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BWIN - US05589G1022 - Common Stock

23.69 USD
-0.19 (-0.8%)
Last: 12/19/2025, 8:00:02 PM
23.83 USD
+0.14 (+0.59%)
After Hours: 12/19/2025, 8:00:02 PM
Fundamental Rating

4

BWIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 148 industry peers in the Insurance industry. BWIN has a bad profitability rating. Also its financial health evaluation is rather negative. BWIN is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BWIN had positive earnings in the past year.
BWIN had a negative operating cash flow in the past year.
BWIN had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BWIN reported negative operating cash flow in multiple years.
BWIN Yearly Net Income VS EBIT VS OCF VS FCFBWIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

BWIN has a Return On Assets of -0.74%. This is amonst the worse of the industry: BWIN underperforms 85.81% of its industry peers.
With a Return On Equity value of -4.54%, BWIN is not doing good in the industry: 84.46% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 2.28%, BWIN is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -0.74%
ROE -4.54%
ROIC 2.28%
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BWIN Yearly ROA, ROE, ROICBWIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

Looking at the Operating Margin, with a value of 5.49%, BWIN is doing worse than 72.97% of the companies in the same industry.
With an excellent Gross Margin value of 27.16%, BWIN belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
BWIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.49%
PM (TTM) N/A
GM 27.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
BWIN Yearly Profit, Operating, Gross MarginsBWIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWIN is destroying value.
The number of shares outstanding for BWIN has been increased compared to 1 year ago.
The debt/assets ratio for BWIN is higher compared to a year ago.
BWIN Yearly Shares OutstandingBWIN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BWIN Yearly Total Debt VS Total AssetsBWIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BWIN has an Altman-Z score of 0.96. This is a bad value and indicates that BWIN is not financially healthy and even has some risk of bankruptcy.
BWIN's Altman-Z score of 0.96 is fine compared to the rest of the industry. BWIN outperforms 79.05% of its industry peers.
BWIN has a Debt/Equity ratio of 2.64. This is a high value indicating a heavy dependency on external financing.
BWIN has a worse Debt to Equity ratio (2.64) than 94.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACC0.28
WACC8.03%
BWIN Yearly LT Debt VS Equity VS FCFBWIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

BWIN has a Current Ratio of 1.15. This is a normal value and indicates that BWIN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BWIN (1.15) is better than 81.76% of its industry peers.
BWIN has a Quick Ratio of 1.15. This is a normal value and indicates that BWIN is financially healthy and should not expect problems in meeting its short term obligations.
BWIN's Quick ratio of 1.15 is amongst the best of the industry. BWIN outperforms 81.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
BWIN Yearly Current Assets VS Current LiabilitesBWIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

BWIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.44%, which is quite impressive.
Measured over the past years, BWIN shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.83% on average per year.
Looking at the last year, BWIN shows a quite strong growth in Revenue. The Revenue has grown by 10.69% in the last year.
BWIN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.78% yearly.
EPS 1Y (TTM)20.44%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%-6.06%
Revenue 1Y (TTM)10.69%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%7.8%

3.2 Future

Based on estimates for the next years, BWIN will show a very strong growth in Earnings Per Share. The EPS will grow by 23.22% on average per year.
Based on estimates for the next years, BWIN will show a quite strong growth in Revenue. The Revenue will grow by 14.05% on average per year.
EPS Next Y13.29%
EPS Next 2Y17.29%
EPS Next 3Y19.71%
EPS Next 5Y23.22%
Revenue Next Year9.14%
Revenue Next 2Y10.05%
Revenue Next 3Y11.14%
Revenue Next 5Y14.05%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BWIN Yearly Revenue VS EstimatesBWIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
BWIN Yearly EPS VS EstimatesBWIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.36 indicates a correct valuation of BWIN.
BWIN's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of BWIN to the average of the S&P500 Index (26.39), we can say BWIN is valued slightly cheaper.
The Price/Forward Earnings ratio is 11.48, which indicates a very decent valuation of BWIN.
BWIN's Price/Forward Earnings is on the same level as the industry average.
BWIN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.36
Fwd PE 11.48
BWIN Price Earnings VS Forward Price EarningsBWIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BWIN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BWIN is more expensive than 68.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.17
BWIN Per share dataBWIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BWIN's earnings are expected to grow with 19.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.08
PEG (5Y)N/A
EPS Next 2Y17.29%
EPS Next 3Y19.71%

0

5. Dividend

5.1 Amount

No dividends for BWIN!.
Industry RankSector Rank
Dividend Yield 0%

BALDWIN INSURANCE GROUP INC/

NASDAQ:BWIN (12/19/2025, 8:00:02 PM)

After market: 23.83 +0.14 (+0.59%)

23.69

-0.19 (-0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners112.74%
Inst Owner ChangeN/A
Ins Owners0.95%
Ins Owner Change-1.81%
Market Cap2.81B
Revenue(TTM)1.49B
Net Income(TTM)-28.11M
Analysts77.33
Price Target34.3 (44.79%)
Short Float %10.1%
Short Ratio6.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0%
Min EPS beat(2)-1.3%
Max EPS beat(2)1.31%
EPS beat(4)2
Avg EPS beat(4)0.73%
Min EPS beat(4)-1.3%
Max EPS beat(4)4.03%
EPS beat(8)5
Avg EPS beat(8)3.11%
EPS beat(12)7
Avg EPS beat(12)2.13%
EPS beat(16)10
Avg EPS beat(16)2.94%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-0.93%
Revenue beat(8)0
Avg Revenue beat(8)-1.58%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.51%
PT rev (3m)-18.84%
EPS NQ rev (1m)0.77%
EPS NQ rev (3m)-3%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 14.36
Fwd PE 11.48
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B 4.54
P/tB N/A
EV/EBITDA 22.17
EPS(TTM)1.65
EY6.96%
EPS(NY)2.06
Fwd EY8.71%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS12.54
BVpS5.22
TBVpS-16.13
PEG (NY)1.08
PEG (5Y)N/A
Graham Number13.93
Profitability
Industry RankSector Rank
ROA -0.74%
ROE -4.54%
ROCE 2.88%
ROIC 2.28%
ROICexc 2.35%
ROICexgc 30.57%
OM 5.49%
PM (TTM) N/A
GM 27.16%
FCFM N/A
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF N/A
Debt/EBITDA 8.3
Cap/Depr 36.29%
Cap/Sales 2.81%
Interest Coverage 0.71
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 0.96
F-Score5
WACC8.03%
ROIC/WACC0.28
Cap/Depr(3y)30.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.44%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%-6.06%
EPS Next Y13.29%
EPS Next 2Y17.29%
EPS Next 3Y19.71%
EPS Next 5Y23.22%
Revenue 1Y (TTM)10.69%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%7.8%
Revenue Next Year9.14%
Revenue Next 2Y10.05%
Revenue Next 3Y11.14%
Revenue Next 5Y14.05%
EBIT growth 1Y124.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.63%
EBIT Next 3Y50.86%
EBIT Next 5Y36.26%
FCF growth 1Y187.63%
FCF growth 3Y24.41%
FCF growth 5YN/A
OCF growth 1Y128.81%
OCF growth 3Y36.54%
OCF growth 5YN/A

BALDWIN INSURANCE GROUP INC/ / BWIN FAQ

What is the ChartMill fundamental rating of BALDWIN INSURANCE GROUP INC/ (BWIN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BWIN.


Can you provide the valuation status for BALDWIN INSURANCE GROUP INC/?

ChartMill assigns a valuation rating of 4 / 10 to BALDWIN INSURANCE GROUP INC/ (BWIN). This can be considered as Fairly Valued.


How profitable is BALDWIN INSURANCE GROUP INC/ (BWIN) stock?

BALDWIN INSURANCE GROUP INC/ (BWIN) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for BWIN stock?

The Earnings per Share (EPS) of BALDWIN INSURANCE GROUP INC/ (BWIN) is expected to grow by 13.29% in the next year.